Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose

medRxiv(2022)10.1101/2022.01.06.22268745Source: DataRank Database

Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

gisaid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (28)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (30)

Hope R. Lapointe ORCID,Peter K. Cheung ORCID,Yurou Sang,Fatima Yaseen,Gisele Umviligihozo ORCID

Live enrichment

PubMed:35018381 OpenAlex:https://openalex.org/W4205819516

Wellcome Trust

Grant: 107752/Z/15/Z

Wellcome Trust

Grant: 107752

Sub-Saharan African Network for TB/HIV research Excellence (SANTHE)

Canadian Institutes of Health Research

Grant: unidentified

unidentified

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/02/21/2022.01.06.22268745.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.01.06.22268745

repositoryhttps://doi.org/10.1101/2022.01.06.22268745

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35018381

Fields of Study

SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinationsCOVID-19 Clinical Research Studies0301 basic medicine03 medical and health sciences

Keywords

Coronavirus disease 2019 (COVID-19)VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineImmunologyInternal medicineOutbreakInfectious disease (medical specialty)Vaccines, SyntheticCOVID-19 VaccinesSARS-CoV-2COVID-19Antibodies, ViralAntibodies, NeutralizingArticleSpike Glycoprotein, CoronavirusMajor ArticleHumansAngiotensin-Converting Enzyme 2RNA, MessengermRNA VaccinesAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: No poverty

Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose

FAIR Checklist

Authors (30)

Funding (3 grants)

Open Access

Topics

Annotations (Europe PMC)